Clinical Study

The Incidence and Predictors of Thromboembolic Events in Patients with Lung Cancer

Table 4

Hemostatic factors “cut-offs” for venous thromboembolic events.

Any VTESerious VTE
AUC (95% CI)1 SensitivitySpecificityCutoffAUC (95% CI)1 SensitivitySpecificityCut Off

Platelets 0.68 (0.63–0.74) <0.001 0.7470.568299.50.69 (0.63–0.75) <0.001 0.6750.638330.5
WBC0.58 (0.52–0.63) 0.017 0.5600.6026.360.57 (0.51–0.63) 0.042 0.5380.5986.36
Hemoglobin0.54 (0.48–0.61)0.1800.5820.463123.50.54 (0.47–0.61)0.2610.5750.462123.5
PT0.51 (0.44–0.57)0.8350.5520.4871.050.51 (0.44–0.58)0.7510.5660.4881.05
aPTT0.54 (0.48–0.61)0.1940.5170.59735.950.55 (0.48–0.62)0.1480.5390.59735.95
Fibrinogen0.53 (0.46–0.60)0.4350.5730.5323.150.53 (0.45–0.60)0.4800.5140.5843.35
D dimers0.56 (0.48–0.63)0.1170.4380.6790.400.54 (0.46–0.63)0.2490.4920.5920.38

ROC analysis.